MedicNest.euLive Grid

bt_bb_section_bottom_section_coverage_image

Dates: 01/01/2020 31/12/2025 Topic: Biomarkers identification AI/Big Data DRUG Project type: Clinic Project target: Infectious Disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: UNIVERSIDAD CARLOS III DE MADRID Keywords: drug discovery; AI; diabetes; tuberculosis; oral drug; infectius disease; clinical trial Countries:...

Dates: 01/10/2020 31/12/2024 Topic: Tool AI/Big data Project type: Preclinic Clinic Theranostic Project target: Cervical Cancer Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.2. – Preventing disease Participating agents: STICHTING VUMC Keywords: screening; cervical cancer; tumour; HPV; cytology; DNA; e-health; vaccine; clinical trial Countries: Netherlands; Sweden; France; Finland; Spain; Belgium; Slovenia;...

Dates: 01/01/2019 31/03/2025 Topic: Biomarkers identification Tool AI/Big Data Project type: Preclinic Clinic Project target: Other Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.2. – Preventing disease Participating agents: EUROPEAN FOUNDATION FOR THE STUDY OF CHRONIC LIVER FAILURE (EF-CLIF) Keywords: liver cihrrosis; biomarker; clinical trial; ACLF; acute-on-chronic liver failure; OMICs; hepatology;...

Dates: 01/06/2021 31/05/2028 Topic: Procedures Project type: Clinic Project target: Infectious disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM Keywords: tuberculosis; drug resistance; machine learning; microbiology; simulation software; tool; procedure; clinical trial; biomarker Countries: Netherlands; UK;...

Dates: 01/01/2020 31/12/2024 Topic: Biomarkers identification Project type: Preclinic Clinic Immunotherapy Project target: Infectious disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.3. – Treating and managing disease Other Participating agents: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE Keywords: hepatitis B; vaccine; CHB; biomarker; clinical trial; public health;...

Dates: 01/06/2018 31/05/2023 Topic: Biomarkers identification Procedures Project type: Preclinic Clinic Project target: Neurology Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being MAIN PROGRAMME H2020-EU.3.1.7. – Innovative Medicines Initiative 2 (IMI2) Other Participating agents: KING’S COLLEGE LONDON Keywords: Autism Spectrum Disorder; clinical trial; biomarker; procedures; network; consortium Countries: UK; Switzerland; Netherlands; Spain;...

Dates: 01/04/2018 31/03/2023 Topic: Tool AI/Big data Project type: Preclinic Clinic Theranostic Project target: Neurology Colorectal Cancer Digestive disease Financing: H2020-EU.1.1. – EXCELLENT SCIENCE – European Research Council (ERC) Participating agents: NATIONAL UNIVERSITY OF IRELAND GALWAY Keywords: nutrition; microbiote; gut; clinical trial; drug response; model; metabolism; diet; metabolit; colon cancer; Parkinson’s disease; levodopa Countries: Ireland...

Dates: 01/01/2020 31/12/2024 Topic: Biomarkers identification Strategies Project type: Preclinic Clinic Project target: Infectious disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.3. – Treating and managing disease Participating agents: CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES Keywords: hospital-acquired pneumonia; pneumonology; antibiotic; infectious disease; drug resistance; biomarker; strategy; OMICs; clinical trial; procedure Countries:...

Dates: 01/02/2018 31/07/2023 Topic: Tool AI/Big Data Project type: Preclinic Project target: Neurology Cardiovascular disease Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.5. – Methods and data Participating agents: UNIVERSITEIT MAASTRICHT Keywords: drug repurposing; biomarker; cerebro-cardiovascular; in-silico; clinical trial; efficacy Countries: Denmark; UK; Germany; Netherlands; Austria Project page: Access page